Cite
Rassi-Cruz M, Maria AG, Faucz FR, et al. Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism. Endocr Relat Cancer. 2021;28(1):1-13doi: 10.1530/ERC-20-0384.
Rassi-Cruz, M., Maria, A. G., Faucz, F. R., London, E., Vilela, L. A. P., Santana, L. S., Benedetti, A. F. F., Goldbaum, T. S., Tanno, F. Y., Srougi, V., Chambo, J. L., Pereira, M. A. A., Cavalcante, A. C. B. S., Carnevale, F. C., Pilan, B., Bortolotto, L. A., Drager, L. F., Lerario, A. M., Latronico, A. C., Fragoso, M. C. B. V., Mendonca, B. B., Zerbini, M. C. N., Stratakis, C. A., & Almeida, M. Q. (2021). Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism. Endocrine-related cancer, 28(1), 1-13. https://doi.org/10.1530/ERC-20-0384
Rassi-Cruz, Marcela, et al. "Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism." Endocrine-related cancer vol. 28,1 (2021): 1-13. doi: https://doi.org/10.1530/ERC-20-0384
Rassi-Cruz M, Maria AG, Faucz FR, London E, Vilela LAP, Santana LS, Benedetti AFF, Goldbaum TS, Tanno FY, Srougi V, Chambo JL, Pereira MAA, Cavalcante ACBS, Carnevale FC, Pilan B, Bortolotto LA, Drager LF, Lerario AM, Latronico AC, Fragoso MCBV, Mendonca BB, Zerbini MCN, Stratakis CA, Almeida MQ. Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism. Endocr Relat Cancer. 2021 Jan;28(1):1-13. doi: 10.1530/ERC-20-0384. PMID: 33112806; PMCID: PMC7757641.
Copy
Download .nbib